Nevro Funding History

Since Nevro was founded in 2006, it has participated in 7 rounds of funding. In total Nevro has raised $633.1M. Nevro's last funding round was on Nov 2023 for a total of $200.0M.

Nevro Funding Rounds

Post-IPO Debt

Nov 2023

$200M

Post-IPO Debt

Jun 2016

$173M

IPO

May 2014

$126M

Series C

Mar 2013

$48M

Novo Ventures, New Enterprise Associates, Covidien Ventures, Accuitive Medical Ventures, Bay City Capital, Johnson & Johnson Development Corporation, Mayo Clinic Rochester, MPM Capital, Three Arch Partners

Series B

Jul 2011

$58.6M

Johnson & Johnson Development Corporation, Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, Mayo Clinic Rochester, MPM Capital, Three Arch Partners

Nevro Investors

Novo Ventures

Series C

Mar 2013

New Enterprise Associates

Series C

Mar 2013

Covidien Ventures

Series C

Mar 2013

Accuitive Medical Ventures

Series C, Series B, Series A

Mar 2013, Jul 2011, Sep 2008

Bay City Capital

Series C, Series B

Mar 2013, Jul 2011

Nevro has 12 investors, including Novo Ventures, New Enterprise Associates and Covidien Ventures. The latest investment occurred in Nov 2023.

Nevro Funding History

Since Nevro was founded in 2006, it has participated in 7 rounds of funding. In total Nevro has raised $633.1M. Nevro's last funding round was on Nov 2023 for a total of $200.0M.

Nevro Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Total Funding: $633.1M

Nevro Investors

INVESTOR

ROUND

FUNDING DATE

Total Investors: 12